Evidence map›Paper›PMID 40766469›Full record

ArticlebioRxiv : the preprint server for biology2025

A Novel Phosphatase Reverses the Leloir Pathway to Promote Tagatose Synthesis from Glucose.

Aaron M Love, Christopher G Toomey, Abhishek Kumar, Sukesh Narayan Kashyap, Dhinesh Kumar Santhamoorthy, Likith Muthuraj, Hannah L Lynch, Parayil Kumaran Ajikumar, R Pravin Kumar, Nikhil U Nair and 1 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Aaron M LoveManus Bio, Waltham, MA 02453.
Christopher G ToomeyManus Bio, Waltham, MA 02453.
Abhishek KumarKcat Enzymatic Pvt. Ltd., Karnataka 560005, India.
Sukesh Narayan KashyapKcat Enzymatic Pvt. Ltd., Karnataka 560005, India.
Dhinesh Kumar SanthamoorthyKcat Enzymatic Pvt. Ltd., Karnataka 560005, India.
Likith MuthurajKcat Enzymatic Pvt. Ltd., Karnataka 560005, India.
Hannah L LynchManus Bio, Waltham, MA 02453.
Parayil Kumaran AjikumarManus Bio, Waltham, MA 02453.
R Pravin KumarKcat Enzymatic Pvt. Ltd., Karnataka 560005, India.
Nikhil U NairDepartment of Chemical & Biological Engineering, Tufts University, Medford, MA 02155.ORCID 0000-0001-7737-1385
Christine N S SantosManus Bio, Waltham, MA 02453.

Funding

Developing Synthetic Enzymes to Treat Inborn Errors of MetabolismR21HD105934 · NICHD · TUFTS UNIVERSITY MEDFORD · PI NAIR, NIKHIL UNNI · 2022 to 2023
$344k
NICHD NIH HHS R21 HD105934
6 · The paper itself

Abstract

d-Tagatose is a natural, low-calorie, rare monosaccharide that has gained substantial interest as an alternative sweetener. It offers numerous benefits, including a low glycemic index, prebiotic properties, and the ability to lower blood sugar levels. Currently, tagatose is primarily produced industrially through the isomerization of galactose, utilizing both chemical and enzymatic catalysis. While these established processes can produce tagatose, they are inefficient and expensive. Recent works have demonstrated alternative biosynthetic routes to produce d-tagatose but suffer from low theoretical yield and/or reliance on expensive feedstocks. This study demonstrates a novel biochemical pathway to produce d-tagatose directly from glucose using a whole-cell process with

Indexed as

biosynthesisgalactose-1-phosphatehigh yieldisomerasephosphatasewhole cell

Identifiers

PMID40766469
PMCPMC12324327

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.